• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prevalence of hepatitis B surface antigen and antibody in white and black patients with diabetes mellitus.糖尿病白种人和黑种患者中乙肝表面抗原和抗体的流行情况
J Clin Microbiol. 1976 Dec;4(6):467-9. doi: 10.1128/jcm.4.6.467-469.1976.
2
Hepatitis-B surface antigen and antibody in Black and White patients with venereal diseases.患有性病的黑人和白人患者的乙肝表面抗原和抗体
Br J Vener Dis. 1977 Dec;53(6):372-4. doi: 10.1136/sti.53.6.372.
3
The prevalence of hepatitis B surface antigen in Nigerian diabetics.尼日利亚糖尿病患者中乙肝表面抗原的流行情况。
Trop Geogr Med. 1980 Mar;32(1):40-4.
4
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States.美国黑人和白人肝细胞癌患者中乙型和丙型肝炎病毒标志物的流行情况。
J Natl Cancer Inst. 1990 Jun 20;82(12):1038-41. doi: 10.1093/jnci/82.12.1038.
5
Antibodies against the hepatitis B surface antigen in diabetics.糖尿病患者体内抗乙型肝炎表面抗原的抗体
Diabete Metab. 1977 Mar;3(1):19-21.
6
Prevalence of markers of hepatitis B virus infection in various countries: a WHO collaborative study.各国乙肝病毒感染标志物的流行情况:一项世界卫生组织合作研究
Bull World Health Organ. 1980;58(4):621-8.
7
The frequency of hepatitis A and B viruses as the offending viral type in suspected hepatitis.甲型和乙型肝炎病毒作为疑似肝炎致病病毒类型的出现频率。
S Afr Med J. 1983 Jan 15;63(3):82-5.
8
Prevalence of antibodies to a rotavirus in black and white populations in South Africa.南非黑人和白人中轮状病毒抗体的流行情况。
S Afr Med J. 1978 Feb 4;53(5):159-62.
9
Unexpected lower prevalence of HBsAg in diabetics than in controls. (A study on 2,465 patients).糖尿病患者中乙肝表面抗原(HBsAg)的患病率意外低于对照组。(一项针对2465名患者的研究)
Ric Clin Lab. 1982 Apr-Jun;12(2):409-15. doi: 10.1007/BF02909426.
10
Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.乙型肝炎病毒与原发性肝细胞癌:韩国的家族研究
Int J Cancer. 1982 Jul 15;30(1):47-51. doi: 10.1002/ijc.2910300109.

引用本文的文献

1
Editorial musings.编辑随想
JHEP Rep. 2019 Aug 5;1(2):iv-v. doi: 10.1016/j.jhepr.2019.07.001. eCollection 2019 Aug.
2
Seroprevalence of hepatitis B virus: Findings from a population-based household survey in KwaZulu-Natal, South Africa.南非夸祖鲁-纳塔尔省基于人群的家庭调查中乙型肝炎病毒的血清流行率。
Int J Infect Dis. 2019 Aug;85:150-157. doi: 10.1016/j.ijid.2019.06.005. Epub 2019 Jun 13.
3
Prevalence of hepatitis B virus in patients with diabetes mellitus: a comparative cross sectional study at Woldiya General Hospital, Ethiopia.糖尿病患者中乙型肝炎病毒的流行情况:埃塞俄比亚沃尔迪亚综合医院的一项比较横断面研究。
Pan Afr Med J. 2014 Jan 21;17:40. doi: 10.11604/pamj.2014.17.40.2465. eCollection 2014.
4
Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa.非洲全面控制乙型肝炎的进展:来自南非的视角
Gut. 1996;38 Suppl 2(Suppl 2):S31-6. doi: 10.1136/gut.38.suppl_2.s31.
5
Hepatitis-B surface antigen and antibody in Black and White patients with venereal diseases.患有性病的黑人和白人患者的乙肝表面抗原和抗体
Br J Vener Dis. 1977 Dec;53(6):372-4. doi: 10.1136/sti.53.6.372.

本文引用的文献

1
THE PHAGOCYTIC ACTIVITY OF POLYMORPHONUCLEAR LEUKOCYTES OBTAINED FROM PATIENTS WITH DIABETES MELLITUS.从糖尿病患者获取的多形核白细胞的吞噬活性
J Lab Clin Med. 1964 Jul;64:1-13.
2
Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus.糖尿病患者多形核白细胞的趋化性。
N Engl J Med. 1971 Mar 25;284(12):621-7. doi: 10.1056/NEJM197103252841201.
3
Hemagglutination assay for antigen and antibody associated with viral hepatitis.病毒性肝炎相关抗原和抗体的血凝试验
Science. 1970 Oct 16;170(3955):332-3. doi: 10.1126/science.170.3955.332.
4
The prevalence of hepatitis B (Australia) antigen in Southern Africa.南非乙型肝炎(澳大利亚)抗原的流行情况。
S Afr Med J. 1974 May 11;48(22):941-4.
5
Impaired leukocyte function in patients with poorly controlled diabetes.血糖控制不佳的糖尿病患者白细胞功能受损。
Diabetes. 1974 Jan;23(1):9-15. doi: 10.2337/diab.23.1.9.
6
Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody.采用¹²⁵I 抗体直接放射免疫测定法检测乙型肝炎病毒抗原的流行情况。
J Immunol. 1972 Oct;109(4):834-41.
7
Phytohemagglutinin transformation and circulating lymphocyte subpopulations in insulin-dependent diabetic patients.胰岛素依赖型糖尿病患者的植物血凝素转化与循环淋巴细胞亚群
Diabetes. 1974 Aug;23(8):708-12. doi: 10.2337/diab.23.8.708.
8
Response of peripheral blood lymphocytes from patients with diabetes mellitus to phytohemagglutinin and Candida albicans antigen.糖尿病患者外周血淋巴细胞对植物血凝素和白色念珠菌抗原的反应。
Diabetes. 1972 Aug;21(8):906-7. doi: 10.2337/diab.21.8.906.
9
[Australia antigen (HBAg) in medical personel and diabetic patients (author's transl)].医务人员和糖尿病患者中的澳大利亚抗原(乙肝表面抗原)(作者译)
Cas Lek Cesk. 1974 Nov 7;113(45):1387-9.
10
Reversible abnormalities in phagocytic function in poorly controlled diabetic patients.血糖控制不佳的糖尿病患者吞噬功能的可逆性异常。
Am J Med Sci. 1972 Jun;263(6):451-6. doi: 10.1097/00000441-197206000-00005.

糖尿病白种人和黑种患者中乙肝表面抗原和抗体的流行情况

Prevalence of hepatitis B surface antigen and antibody in white and black patients with diabetes mellitus.

作者信息

Kew M C, MacKay M E, Mindel A, Joffe B I, Kusman B, MacNab G M, Seftel H C

出版信息

J Clin Microbiol. 1976 Dec;4(6):467-9. doi: 10.1128/jcm.4.6.467-469.1976.

DOI:10.1128/jcm.4.6.467-469.1976
PMID:1002826
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC274506/
Abstract

The prevalence of hepatitis B surface antigen (HBSAg) and antibody (anti-HBS) was determined in 531 white and 519 black diabetic outpatients and in appropriate white and black control populations. There was no difference between the prevalence of either HBSAg or anti-HBS in either the white or black diabetics and that in the white and black controls. These findings make it unlikely that the vast majority of patients with diabetes mellitus have either an increased susceptibility to infection by the hepatitis B virus or an impaired ability to clear the virus once they are infected.

摘要

对531名白人糖尿病门诊患者、519名黑人糖尿病门诊患者以及相应的白人和黑人对照人群,测定了乙肝表面抗原(HBSAg)和抗体(抗-HBS)的流行情况。无论是白人还是黑人糖尿病患者,其HBSAg或抗-HBS的流行率与白人和黑人对照人群均无差异。这些研究结果表明,绝大多数糖尿病患者感染乙肝病毒的易感性不太可能增加,或者感染病毒后清除病毒的能力不太可能受损。